By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Theravance, Inc. 

951 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-808-6000 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Theravance (THRX) Announces Name Change To Innoviva, Inc. 1/11/2016 2:28:21 PM
Theravance (THRX) Announces First Subject Dosed In Phase 1 Clinical Trial Of TD-0714, An Inhibitor Of Neprilysin (NEP) 12/9/2015 11:30:07 AM
Theravance (THRX) Announces Preliminary Results Of Tender Offer 12/3/2015 1:11:24 PM
Theravance (THRX) To Present At Two Upcoming Investor Conferences In November 11/9/2015 2:34:18 PM
Theravance (THRX) Announces Commencement Of Self-Tender Offer For Up To $75,000,000 Of Its Common Stock 11/2/2015 1:57:00 PM
Theravance (THRX) To Report Third Quarter 2015 Financial Results On November 9, 2015 10/28/2015 1:03:20 PM
Theravance (THRX) Reports Third Quarter 2015 Financial Results 10/28/2015 7:35:20 AM
Theravance (THRX) To Report Third Quarter 2015 Financial Results On October 28, 2015 10/22/2015 4:12:30 PM
GlaxoSmithKline (GSK) And Theravance (THRX) Announce Results From The SUMMIT COPD CV Survival Study 9/9/2015 8:54:57 AM
GlaxoSmithKline (GSK), Theravance (THRX)'s Breo Fails to Extend Lives in Ambitious Study 9/8/2015 12:45:37 PM
12345678910...
//-->